Dermed er eliminationshalveringstiden forlænget, hvilket fører til øgede plasmakoncentrationer af metformin.
When renal function is impaired, renal clearance is decreased in proportion to that of creatinine and thus the elimination half-life is prolonged, leading to increased levels of metformin in plasma.